CIK: 0001056807 · Show all filings
Period: Q4 2021 (← Previous) (Next →)
Filing Date: Feb 14, 2022
Total Value ($000): $2,755,083 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| GHRS | GH RESEARCH PLC | 9,275,158 | $216,389 | 7.9% | $20.43 | +7.6% | ORDINARY SHARES | G3855L106 |
| KYMR | KYMERA THERAPEUTICS INC | 3,180,658 | $201,940 | 7.3% | $35.27 | +65.1% | COM | 501575104 |
| RCUS | ARCUS BIOSCIENCES INC | 3,398,067 | $137,520 | 5.0% | $27.66 | +40.2% | COM | 03969F109 |
| — | MERUS N V | 4,135,071 | $131,495 | 4.8% | $31.80 | — | COM | N5749R100 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 3,651,759 | $124,890 | 4.5% | $17.08 | +85.1% | COM | 74366E102 |
| XENE | XENON PHARMACEUTICALS INC | 3,289,540 | $102,765 | 3.7% | $20.97 | +42.5% | COM | 98420N105 |
| — | REPARE THERAPEUTICS INC | 4,858,761 | $102,471 | 3.7% | $28.59 | — | COM | 760273102 |
| RLAY | RELAY THERAPEUTICS INC | 3,130,605 | $96,141 | 3.5% | $35.80 | -11.7% | COM | 75943R102 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 3,003,879 | $85,340 | 3.1% | $23.44 | +5.2% | COM | 22663K107 |
| CGEM | CULLINAN ONCOLOGY INC | 5,369,459 | $82,851 | 3.0% | $22.77 | -12.4% | COM | 230031106 |
| ARGX | ARGENX SE | 216,204 | $75,712 | 2.7% | $283.65 | — | SPONSORED ADR | 04016X101 |
| XOMA | XOMA CORP DEL | 3,530,543 | $73,612 | 2.7% | $15.45 | +51.3% | COM NEW | 98419J206 |
| OLMA | OLEMA PHARMACEUTICALS INC | 7,411,503 | $69,372 | 2.5% | $44.24 | -53.2% | COM | 68062P106 |
| GLPG | GALAPAGOS NV | 1,156,393 | $63,752 | 2.3% | $52.69 | — | SPON ADR | 36315X101 |
| LXRX | LEXICON PHARMACEUTICALS INC | 14,360,000 | $56,578 | 2.1% | $2.82 | +72.2% | COM NEW | 528872302 |
| — | AMARIN CORP PLC | 16,459,965 | $55,470 | 2.0% | $4.54 | — | SPONS ADR NEW | 023111206 |
| — | EQRX INC | 7,859,670 | $53,603 | 1.9% | $6.82 | — | COM | 26886C107 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 2,099,714 | $45,963 | 1.7% | $17.73 | +4.2% | COM | 87164F105 |
| RVMD | REVOLUTION MEDICINES INC | 1,810,549 | $45,572 | 1.7% | $31.40 | -10.2% | COM | 76155X100 |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 2,005,862 | $44,009 | 1.6% | $36.10 | -32.1% | COM | 35104E100 |
| — | ESSA PHARMA INC | 2,851,461 | $40,491 | 1.5% | $6.15 | — | COM NEW | 29668H708 |
| — | RAIN THERAPEUTICS INC | 2,957,807 | $38,097 | 1.4% | $15.34 | — | COM | 75082Q105 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 1,879,412 | $37,156 | 1.3% | $17.69 | +5.3% | COM | 92790C104 |
| RLMD | RELMADA THERAPEUTICS INC | 1,647,400 | $37,116 | 1.3% | $22.24 | 0.0% | COM | 75955J402 |
| — | VERASTEM INC | 17,062,158 | $34,977 | 1.3% | $2.12 | — | COM | 92337C104 |
| ACIU | AC IMMUNE SA | 7,062,379 | $34,959 | 1.3% | $6.69 | -13.2% | SHS | H00263105 |
| — | CHINOOK THERAPEUTICS INC | 1,800,000 | $29,358 | 1.1% | $16.31 | — | COM | 16961L106 |
| KURA | KURA ONCOLOGY INC | 2,064,212 | $28,899 | 1.0% | $16.84 | -3.8% | COM | 50127T109 |
| TYRA | TYRA BIOSCIENCES INC | 1,873,332 | $26,358 | 1.0% | $19.19 | +3.6% | COM | 90240B106 |
| SPRO | SPERO THERAPEUTICS INC | 1,585,615 | $25,386 | 0.9% | $13.39 | +18.7% | COM | 84833T103 |
| CTMX | CYTOMX THERAPEUTICS INC | 5,803,700 | $25,130 | 0.9% | $5.86 | 0.0% | COM | 23284F105 |
| REPL | REPLIMUNE GROUP INC | 926,529 | $25,109 | 0.9% | $35.83 | -16.5% | COM | 76029N106 |
| ACRS | ACLARIS THERAPEUTICS INC | 1,695,904 | $24,658 | 0.9% | $19.80 | -23.5% | COM | 00461U105 |
| — | IKENA ONCOLOGY INC | 1,798,371 | $22,552 | 0.8% | $26.40 | — | COM | 45175G108 |
| — | CTI BIOPHARMA CORP | 8,929,690 | $22,146 | 0.8% | $3.49 | — | COM | 12648L601 |
| — | ALPINE IMMUNE SCIENCES INC | 1,589,495 | $22,015 | 0.8% | $10.67 | — | COM | 02083G100 |
| WHWK | AADI BIOSCIENCES INC | 899,392 | $21,720 | 0.8% | $30.48 | -17.6% | COM | 00032Q104 |
| OVID | OVID THERAPEUTICS INC | 6,631,051 | $21,286 | 0.8% | $4.28 | -20.0% | COM | 690469101 |
| — | PIERIS PHARMACEUTICALS INC | 5,328,239 | $20,141 | 0.7% | $3.02 | — | COM | 720795103 |
| JANX | JANUX THERAPEUTICS INC | 1,017,314 | $20,072 | 0.7% | $22.27 | -5.9% | COM | 47103J105 |
| PYXS | PYXIS ONCOLOGY INC | 1,791,351 | $19,651 | 0.7% | $11.45 | 0.0% | COMMON STOCK | 747324101 |
| — | CALLIDITAS THERAPEUTICS AB | 750,000 | $18,570 | 0.7% | $23.30 | — | SPONSERED ADS | 13124Q106 |
| — | NGM BIOPHARMACEUTICALS INC | 955,000 | $16,913 | 0.6% | $19.72 | — | COM | 62921N105 |
| — | POINT BIOPHARMA GLOBAL INC | 2,920,526 | $16,355 | 0.6% | $7.58 | — | COM | 730541109 |
| SLN | SILENCE THERAPEUTICS PLC | 666,666 | $15,600 | 0.6% | $23.73 | — | ADS | 82686Q101 |
| INFIQ | INFINITY PHARMACEUTICALS INC | 6,353,645 | $14,296 | 0.5% | $2.67 | -6.1% | COM | 45665G303 |
| — | SUTRO BIOPHARMA INC | 925,148 | $13,766 | 0.5% | $9.22 | — | COM | 869367102 |
| — | GLYCOMIMETICS INC | 9,544,262 | $13,744 | 0.5% | $4.18 | — | COM | 38000Q102 |
| DAWN | DAY ONE BIOPHARMACEUTICALS I | 809,282 | $13,636 | 0.5% | $20.76 | -1.0% | COM | 23954D109 |
| COGT | COGENT BIOSCIENCES INC | 1,532,282 | $13,147 | 0.5% | $10.99 | -20.9% | COM | 19240Q201 |
| — | VIRACTA THERAPEUTICS INC | 3,438,944 | $12,552 | 0.5% | $8.69 | — | COM | 92765F108 |
| — | MOLECULAR TEMPLATES INC | 3,129,599 | $12,268 | 0.4% | $7.01 | — | COM | 608550109 |
| — | CONTRAFECT CORP | 3,972,300 | $10,447 | 0.4% | $5.42 | — | COM NEW | 212326300 |
| — | ELEVATION ONCOLOGY INC | 1,611,698 | $9,702 | 0.4% | $13.47 | — | COM | 28623U101 |
| — | MEI PHARMA INC | 3,532,057 | $9,431 | 0.3% | $3.09 | — | COM NEW | 55279B202 |
| — | CIDARA THERAPEUTICS INC | 6,861,127 | $8,714 | 0.3% | $2.37 | — | COM | 171757107 |
| MOLN | MOLECULAR PARTNERS AG | 443,221 | $8,550 | 0.3% | $19.71 | — | ADS | 60853G106 |
| NUVL | NUVALENT INC | 448,512 | $8,540 | 0.3% | $29.01 | -23.2% | COM | 670703107 |
| IVA | INVENTIVA SA | 544,500 | $7,438 | 0.3% | $14.26 | — | ADS | 46124U107 |
| — | CONCERT PHARMACEUTICALS INC | 2,253,000 | $7,097 | 0.3% | $3.15 | — | COM | 206022105 |
| MIRM | MIRUM PHARMACEUTICALS INC | 435,936 | $6,953 | 0.3% | $16.26 | -4.4% | COM | 604749101 |
| ELDN | ELEDON PHARMACEUTICALS INC | 1,378,020 | $6,077 | 0.2% | $13.51 | -62.6% | COM | 28617K101 |
| — | SELECTA BIOSCIENCES INC | 1,723,133 | $5,617 | 0.2% | $3.14 | — | COM | 816212104 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 454,545 | $5,118 | 0.2% | $11.26 | — | SPONSORED ADS | 152309100 |
| — | EUCRATES BIOMEDICAL ACQU COR | 500,000 | $4,990 | 0.2% | $10.66 | — | UNIT 10/23/2027 | G3141W114 |
| — | CALITHERA BIOSCIENCES INC | 7,452,331 | $4,957 | 0.2% | $3.71 | — | COM | 13089P101 |
| — | FRAZIER LIFESCIENCES ACQU CO | 500,000 | $4,950 | 0.2% | $10.41 | — | UNIT 12/09/2025 | G3710A121 |
| — | 5 01 ACQUISITION CORP | 500,000 | $4,925 | 0.2% | $10.17 | — | COM CL A | 33836P105 |
| — | RESEARCH ALLIANCE CORP II | 500,000 | $4,860 | 0.2% | $10.25 | — | COM CL A | 760873109 |
| GNCAQ | GENOCEA BIOSCIENCES INC | 4,012,404 | $4,654 | 0.2% | $3.93 | -62.1% | COM NEW | 372427401 |
| CRVS | CORVUS PHARMACEUTICALS INC | 1,370,947 | $3,304 | 0.1% | $5.07 | -23.5% | COM | 221015100 |
| — | GALMED PHARMACEUTICALS LTD | 1,799,694 | $3,275 | 0.1% | $11.58 | — | SHS | M47238106 |
| — | ANGION BIOMEDICA CORP | 1,071,297 | $3,107 | 0.1% | $17.04 | — | COM | 03476J107 |
| — | ERYTECH PHARMA | 1,314,656 | $3,103 | 0.1% | $13.01 | — | SPONSORED ADR | 29604W108 |
| — | AILERON THERAPEUTICS INC | 5,265,555 | $2,964 | 0.1% | $1.43 | — | COM | 00887A105 |
| — | JIYA ACQUISITION CORP | 300,000 | $2,931 | 0.1% | $10.30 | — | COM CL A | 47760M102 |
| — | FORWARD PHARMA A/S | 432,892 | $2,584 | 0.1% | $5.81 | — | SPONSORD ADS NEW | 34986J204 |
| ABOS | ACUMEN PHARMACEUTICALS INC | 289,663 | $1,958 | 0.1% | $16.64 | -33.9% | COM | 00509G209 |
| — | X4 PHARMACEUTICALS INC | 847,879 | $1,942 | 0.1% | $11.68 | — | COM | 98420X103 |
| — | GENERATION BIO CO | 189,050 | $1,338 | 0.0% | $7.08 | — | COM | 37148K100 |
| — | BIONOMICS LIMITED | 80,971 | $1,016 | 0.0% | $12.55 | — | ADS | 09063M205 |
| RZLT | REZOLUTE INC | 190,815 | $912 | 0.0% | $19.25 | -69.7% | COM NEW | 76200L309 |
| VYGR | VOYAGER THERAPEUTICS INC | 22,200 | $60 | 0.0% | $2.70 | — | COM | 92915B106 |